Advanced Age Management

05/14/2026

From to More: How To Actually Max Out Your 💪🏽 - Review

A new narrative review, combing PubMed, Scopus, ScienceDirect, and Google Scholar (2010–2024) for RCTs, meta-analyses, and mechanistic work on hypertrophy training, nutrition, and recovery is one of the most comprehensive and certainly most up-to-date I have seen.

➕ Lower-quality evidence and endurance-only studies were filtered out to keep the focus on muscle growth–relevant data.

Let's see what they found



📊 Aim for roughly 10–20 hard sets per muscle group per week, ideally spread over 2–3 sessions, with most sets taken to about 0–2 reps in reserve.

‼️ Mind the volume: Nieto et al. explicitly frame volume as the central driver once you have enough load and effort, with ☝🏽 higher volumes beyond ~20–25 sets more likely to tank recovery than to add meat.



🥩 Protein at about 1.6–2.2 g/kg/day, split into 3–4 meals of ~0.4–0.5 g/kg, is the "sweet spot" to keep MPS switches flipping all day.

☝🏽 They stress that this is one of the highest-confidence levers, anchored in multiple meta-analyses, not a marginal "optimization hack".

!

🍚 Stay in at least energy balance, often with a modest 200–500 kcal/day surplus plus ~3–6 g/kg/day carbs to actually fuel the productive volume.

☝🏽 In practice, that is their anti-"recomp forever" stance: chronic low energy and low carbs = nice AMPK, lousy hypertrophy.



🛌 Sleep 7–9 h/night – short sleep downregulates mTORC1, messes with hormones, and shifts the needle toward muscle loss and fat gain, even in active people.

🤔 The authors are surprisingly blunt that the evidence for sleep is mechanistically strong even if direct hypertrophy RCTs are still catching up.

And how do those gains "work" - the

💪🏽 Mechanistically, they keep circling back to mechanical tension and high-threshold motor unit recruitment as the "on switch" for mTORC1 and downstream protein synthesis.

Metabolic stress and things like BFR are named as supporting actors that can help, but only if effective tension and full fiber recruitment are there.

Satellite cell activation and myostatin suppression are discussed as the longer-term "infrastructure" upgrades that let fibers keep on growing once the early gains are over.

From mechanotransduction and PA/mTOR to weekly sets, protein targets, carbs, and sleep hygiene – all are addressed in this comprehensive review which is clearly reading and a must-read for the self-proclaimed "evidence-based" hypertrophy chaser, however...

🤔 The question remains: Is any of this shocking for the reader?

🙂‍↔️ Not really: "10–20 sets, near failure, 1.6+ g/kg protein, eat enough, sleep" is more consolidation than revolution – but having all of it integrated into a single, pro-science, mechanism-aware hypertrophy review is exactly the sort of reference you want to have bookmarked and send to clients who still think the secret is in the latest exercise or exotic supplement.

| Vergara Nieto ÁA, Halabi Diaz A, Hernández Millán M, Sagredo Oyarzo D. Molecular Basis and Practical Applications of Training, Nutrition and Recovery for Maximum Gains in Lean Muscle Mass: A Narrative Review for Optimizing Muscular Hypertrophy. Sports Health. Published online May 8, 2026. doi:10.1177/19417381261438760

05/14/2026

The latest understanding is that statins are unlikely to cause dementia. They may even lower your risk. A memory and cognitive disorders specialist explains.

05/14/2026

For so long, fat was the enemy…

Low-fat everything. Avoid oils. Skip the yolks.

These “health” guidelines led a lot of people to fear one of the most important nutrients for hormone balance.

Hormones like estrogen, progesterone, and testosterone are built from cholesterol, and fats play a key role in cellular health, signaling, and reducing inflammation.

When you under-consume healthy fats, your body can struggle with:
👉 Hormone production
👉 Blood sugar stability
👉 Energy and satiety

Start adding in more of the right kinds:
👉 Avocados
👉 Olive oil
👉 Grass-fed butter or ghee
👉 Wild-caught fish
👉 Nuts and seeds (chia, flax, walnuts)

I break all of this down in my hormone balancing masterclass…including what’s actually driving your hormone imbalances and how to start restoring them naturally.

Comment ‘HORMONE’ and I’ll send it to you.

05/11/2026

After age 30, your body slowly starts losing more bone than it builds.
Running alone may not fully protect bone density, while yoga and Pilates mainly improve mobility and balance.
Research shows resistance training is one of the most effective ways to maintain stronger bones, reduce bone loss, and lower the risk of osteoporosis as you age.

Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

05/11/2026

A new study is turning one of the world’s most common breakfast foods into a major conversation in brain health research. Scientists found that older adults who regularly consumed eggs showed a 27% lower risk of developing Alzheimer’s disease compared to those who ate fewer eggs. The findings are gaining attention because Alzheimer’s continues to affect millions of families worldwide.

Researchers believe eggs may support brain function because they contain important nutrients like choline, omega 3 fatty acids, lutein, and vitamin B12. Choline is especially important because the brain uses it to produce acetylcholine, a neurotransmitter linked to memory and cognitive performance. Many adults do not get enough choline in their daily diet.

Health experts say the study does not prove eggs directly prevent Alzheimer’s, but it does strengthen growing evidence that nutrition plays a major role in long term brain health. Scientists are increasingly focusing on foods that may help reduce inflammation and support healthy brain aging naturally.

Doctors still recommend balanced eating habits combined with exercise, sleep, and cardiovascular health for the best cognitive protection. Even so, this research has made eggs one of the most discussed foods in the healthy aging conversation right now.

05/11/2026

05/10/2026

Vitamin D isn't really a vitamin. It's a steroid hormone that crosses the blood-brain barrier and acts on receptors throughout the brain, including the hippocampus and entorhinal cortex, where Alzheimer's tau accumulates first.
A Framingham Heart Study analysis tracked this for 16 years.

793 adults. Mean baseline age 39. Vitamin D measured 2002-2005. Brain PET imaging 2016-2019.

Higher midlife 25-hydroxyvitamin D was associated with less tau in the brain regions where Alzheimer's pathology starts: entorhinal cortex, parahippocampal gyrus, fusiform gyrus. The relationship was continuous. More D, less tau, smoothly across the range.

The finding is narrow and specific. Vitamin D was associated with tau (the tangle protein) only. There was no association with amyloid (the plaque protein).

The mechanism that fits: vitamin D modulates GSK-3β, the kinase that phosphorylates tau. It's also anti-inflammatory in brain immune cells. These mechanisms are tau-relevant, not particularly amyloid-relevant.
A few qualifications.

This is observational. It cannot prove vitamin D causes lower tau. People developing early pathology may handle vitamin D differently. Reverse causation can't be ruled out.

The clinical cutoff of 30 ng/mL did not reach statistical significance. Only the continuous relationship did. The data doesn't support "below 30 is bad." It supports "more is generally better, smoothly, across the range studied."
The effect size in absolute terms is small. A measurable association, not dramatic protection.

The study did not test supplementation. It measured naturally varying serum levels. Whether pushing your D up with a pill produces the same association is untested.
Practical framing.

Most vitamin D research focused on adults over 65. By 65, tau accumulation has been happening for two decades. The Framingham data suggests the actionable window is earlier.
A reasonable read: test 25-hydroxyvitamin D in your 30s and 40s. The standard reference range labels 30 ng/mL as "sufficient," but in this analysis the association continued above that level. Higher D tracked with less tau across the range.

Reasonable. Not proven causal.

The popular framing of this study is "vitamin D prevents Alzheimer's." The actual finding: a midlife blood marker tracks with a specific brain protein decades later, and the mechanism that fits is narrow and tau-specific.

Mulligan et al., Neurology Open Access, 2026
DOI: 10.1212/WN9.0000000000000057

05/08/2026

Biological age is not a fixed number. The research supports meaningful plasticity in the rate of biological aging based on consistent lifestyle choices.

05/08/2026

Most people who take CoQ10 think of it as an antioxidant. It is one. But that is not the most important thing it does.

CoQ10 is the only mobile electron carrier in the inner mitochondrial membrane. The electron transport chain has four protein complexes fixed in the membrane. Complex I accepts electrons from NADH. Complex II accepts them from FADH2. But neither can pass those electrons directly to Complex III. They hand them to CoQ10, which physically shuttles across the lipid bilayer to deliver them. Complex III passes them to Complex IV, which reduces oxygen to water and drives the proton gradient that ATP synthase uses to produce ATP.

Without CoQ10, the chain breaks between Complex I/II and Complex III. Electrons have nowhere to go. The proton gradient collapses. ATP production stalls. This is not an antioxidant function. This is the core mechanism of aerobic energy production.

CoQ10 is predominantly synthesized endogenously through the mevalonate pathway, the same pathway that produces cholesterol. HMG-CoA reductase is the rate-limiting enzyme. Statins inhibit HMG-CoA reductase. That is how they lower cholesterol. It is also how they lower CoQ10.

An updated meta-analysis by Qu et al. (2018) pooled 12 RCTs with 1,776 participants and found statins significantly reduced circulating CoQ10. The reduction was independent of statin type, intensity, or treatment duration. Both lipophilic and hydrophilic statins produced the same effect. This is consistent with what the biochemistry predicts: the pathway is shared.

On top of statin-induced depletion, CoQ10 in human heart tissue declines naturally with age. Kalén et al. (1989) measured CoQ10 concentrations in myocardial tissue and found levels peak around age 20, decline by more than 30% by age 40, and drop approximately 50% by age 80. The organ with the highest energy demand loses half its electron carrier over a lifetime.

A 2025 meta-analysis by Kovacic et al. (Journal of Nutritional Science, 7 RCTs, 389 patients) found CoQ10 supplementation significantly reduced statin-associated muscle symptoms measured by pain intensity. This is the most current pooled data on clinical outcomes.

One important nuance: while plasma CoQ10 depletion from statins is well established, whether intramuscular CoQ10 drops proportionally is inconsistent. Some studies found no change or even increases in muscle tissue CoQ10 during statin treatment. The plasma reduction may partly reflect reduced LDL particles, which are the primary carriers of CoQ10 in blood. The clinical significance of depletion beyond muscle symptoms remains debated.

Roughly 200 million people worldwide take statins. The mevalonate pathway that produces their target also produces the electron carrier their mitochondria depend on. The mechanism is not controversial. The clinical implications are still being defined.

Kalén et al., Lipids, 1989.

Qu et al., Eur J Med Res, 2018.

Kovacic et al., J Nutr Sci, 2025.

05/08/2026

Muscle strength is one of the most reliable predictors of how long you live. The simplest way to measure it is to squeeze a handheld dynamometer for 30 seconds. The kilograms get recorded. That single number tracks with mortality across nearly every cause researchers have measured.

The Prospective Urban Rural Epidemiology study followed 139,691 adults across 17 countries on five continents for a median of 4 years. Every 5 kilogram drop in grip strength tracked with 16% higher all-cause mortality. The same direction and magnitude held up for cardiovascular death, non-cardiovascular death, heart attack, and stroke. 3,379 deaths occurred over the follow-up period and the relationship persisted after adjustment for age, s*x, education, smoking, alcohol, physical activity, and country.

The headline finding came from a separate analysis. When grip strength and systolic blood pressure were both placed in the same model, grip was the stronger predictor of all-cause and cardiovascular mortality. Blood pressure is the most universally measured risk factor on earth. A squeeze test outperformed it.

Grip strength is a proxy for whole-body muscle strength. It correlates with quadriceps strength, with overall lean mass, and with neuromuscular function. The European Working Group on Sarcopenia in Older People uses grip as the primary measure of muscle strength in their diagnostic criteria.

The mechanism is straightforward. Skeletal muscle is the largest insulin sensitive tissue in the body. It is the primary engine of glucose disposal, the largest reservoir of amino acids, and an endocrine organ that secretes myokines during contraction. When that tissue degrades, the entire metabolic system loses its main shock absorber. Weaker bodies die earlier across a long list of causes.

The PURE data is observational. It does not prove that getting stronger causes lower mortality, only that the strength signal is consistent across continents, across country income levels, and across cause of death.

Almost every adult who walks into a clinic gets a blood pressure measurement. Almost none get their grip strength measured. Your blood pressure cuff misses this. A dynamometer doesn't.

Strength is a vital sign.

Leong et al., Lancet, 2015